Work

Final analysis of phase II study of EZN-2208 (PEG-SN38) in metastatic breast cancer (MBC).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.1017

Authors: Cynthia R. C. Osborne, Joyce O'Shaughnessy, Frankie Ann Holmes, Hyun Sue Kim, Darren M. Kocs, Michael S. Steinberg, Paul D. Richards, Svetislava J. Vukelja, Noah C. Berkowitz, Aby Buchbinder

Institutions: Rocky Mountain Cancer Centers, Virginia Oncology Associates, Salem VA Medical Center, Enzon Pharmaceuticals (United States)

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598178845

Cites:

Cited by: 10

Related to: 10